But similarly when starting insulin in people with T2DM in ambulatory care (as opposed to stress environments such as in‐patients), and including those with possible latent auto‐immune diabetes of adults, the point should be honestly made that this is for life, that it will benefit future health, and that doses and types of insulin will change over the years.19 This evidence concerns the gene INS and type 2 diabetes mellitus.